A revolution is coming to radiology services. Artificial intelligence (AI) and advanced analytics are helping to deliver better patient outcomes more efficiently.

As part of our commitment to Elevating Radiology, we’re exclusively partnering with the European Society of Radiology to put the spotlight on AI at ECR 2019. The event will also see the European launch of Edison – our intelligence offering comprised of applications and smart devices – offering radiologists a better way to manage imaging services.

Healthcare organizations are under increasing pressure to improve efficiency. They need to streamline workflows to cope with rising patient numbers but must still maintain quality and simultaneously reduce costs. Performing the right scan – and delivering the right result – first time depends on having the correct software and imaging equipment. We understand these challenges and have more than 25 years of experience in advanced analytics and AI. Together with partners from academic hospitals, technology industries and independent software vendors, we have developed Edison, a novel offering to help resolve these issues and futureproof your investment.

Our Edison Applications are designed to help you optimize your workflows, reduce errors and waste, and control costs, allowing you to focus on patient care. Edison Applications leverage analytics – such as AI, machine learning, algorithms and models – to identify insights, patterns and suggestions which, in turn, help to enhance and augment clinical, financial and operational decision-making.

Join us on booth #304 - X3 at ECR 2019 to learn more about Elevating Radiology with Edison.


Sunday | October 14 | 13:00-14:30 | Hall Y

New avenues in Molecular imaging
Chairman: Prof. G. Von Schulthess, Zürich, Switzerland

Molecular theranostics in abdominal tumors
Dr. I. Burger, Zürich, Switzerland

PET imaging with deviceless respiratory gating
Dr. D. McGowan, Oxford, United Kingdom

Improved image quality and patient comfort with innovative SPECT design
Dr. G. Métrard, Orléans, France

How can CZT technology improve the patient management in DaT imaging?
Prof. C. Scheiber, Lyon, France

Nuclear Medicine

Five new nuclear medicine systems designed to help clinicians achieve exceptional outcomes.

The new 800 Series includes a collection of SPECT enhancements like SwiftScan Planar and SwiftScan SPECT that help increase sensitivity and enable reducing scan times or injected dose by up to 25 percent1, without affecting signal-to-noise ratio. It also includes the all-new SmartConsole. This digital processing platform modernizes nuclear medicine workflow by automating SPECT/CT reconstruction and enabling scan reviews from remote mobile devices.

1 Compared to LEHR without Planar Clarity2D / SPECT S&S Continuous. As demonstrated in phantom testing using a bone scan protocol and a model observer. Because model observer results may not always match those from a human reader, the actual time/dose reduction depends on the clinical task, patient size, anatomical location and clinical practice. A radiologist should determine the appropriate scan time/dose for the particular clinical task.

PET Imaging

Discovery™ MI now features a unique deviceless respiratory motion management

Discovery MI, available in three scalable detector configurations, is the industry’s only PET/CT system that brings together the ultra-high sensitivity of digital detection with innovative reconstruction technology. The combination of TOF, MotionFree (deviceless motion management), and Q.Clear results in outstanding detection of small lesions and quantification accuracy.

SIGNA™ PET/MR with QuantWorks

Built with pioneering TOF and integrated with a 3.0T MR, its impressive quantitative accuracy and high count rate combined with innovative Q.Clear reconstruction delivers 2x improvement in image quality. In addition, SIGNA PET/MR with QuantWorks includes a comprehensive suite of applications and flexible research tools to pursue ideas that could influence the future of medicine.


It’s time to explore the clinical potential of 68Ga

PETtrace™ 800 Series of cyclotrons provides a cost effective and efficient solution. It includes in-target 68Ga production capability, together with purification and labeling using a single cassette on our FASTlab™ Developer automated chemistry platform.